# AACT Database Download Instructions

## Overview
To perform a comprehensive analysis of ALL antibody therapeutics from the AACT database, you need to download the complete dataset from ClinicalTrials.gov.

## Download Options

### Option 1: Direct Download from AACT Website
1. Visit: https://aact.ctti-clinicaltrials.org/downloads
2. Click on "Download AACT Database"
3. Choose the format:
   - **PostgreSQL**: Complete database (recommended)
   - **CSV Files**: Individual table exports
   - **Monthly Export**: Latest monthly snapshot

### Option 2: Programmatic Download
The comprehensive analysis script will attempt to download the data automatically, but you may need to:

1. **Install required packages**:
```bash
pip install pandas requests
```

2. **Run the comprehensive analysis**:
```bash
python3 comprehensive_antibody_analysis.py
```

### Option 3: Manual Download and Setup
If automatic download fails:

1. **Download from AACT website**:
   - Go to https://aact.ctti-clinicaltrials.org/downloads
   - Download the CSV export files
   - Extract to a folder named `aact_data`

2. **Required files**:
   - `studies.csv` - Trial information
   - `interventions.csv` - Drug and treatment details
   - `adverse_events.csv` - Safety data
   - `conditions.csv` - Disease areas
   - `sponsors.csv` - Study sponsors

3. **Run analysis**:
```bash
python3 comprehensive_antibody_analysis.py
```

## Expected Data Size
- **Total studies**: ~400,000+ clinical trials
- **Interventions**: ~1,000,000+ drug interventions
- **Adverse events**: ~2,000,000+ safety events
- **Antibody trials**: ~10,000-50,000 (estimated)

## What the Analysis Will Extract

### Antibody Identification
The script uses comprehensive patterns to identify ALL antibody therapeutics:

1. **General terms**: antibody, monoclonal antibody, mab
2. **Immunoglobulin terms**: IgG, IgM, IgA, IgE, IgD
3. **Anti- patterns**: anti-CD20, anti-HER2, anti-VEGF
4. **Specific names**: rituximab, trastuzumab, pembrolizumab
5. **Biological classification**: biologic, immunotherapy
6. **Target patterns**: PD-1, PD-L1, CTLA-4, HER2, VEGF

### Antibody Categories
The analysis will categorize antibodies by target:

- **Anti-CD20**: Rituximab, Obinutuzumab, Ofatumumab
- **Anti-HER2**: Trastuzumab, Pertuzumab
- **Anti-VEGF**: Bevacizumab, Ranibizumab
- **Anti-PD-1**: Pembrolizumab, Nivolumab
- **Anti-PD-L1**: Atezolizumab, Durvalumab
- **Anti-CTLA-4**: Ipilimumab, Tremelimumab
- **Anti-TNF**: Adalimumab, Infliximab
- **And many more...**

### Toxicity Analysis
For each antibody, the analysis will extract:

1. **Study details**: Phase, enrollment, duration
2. **Patient demographics**: Age, gender, performance status
3. **Adverse events**: All reported toxicities
4. **Serious events**: Life-threatening or fatal events
5. **Organ systems**: Affected body systems
6. **Management**: Treatment strategies and outcomes

## Expected Output

### Files Generated
1. **`comprehensive_antibody_toxicity_table.csv`** - Complete dataset
2. **`comprehensive_antibody_analysis_report.md`** - Detailed report
3. **Summary tables** with key findings

### Key Metrics
- Total antibody trials identified
- Number of unique antibody therapeutics
- Adverse event frequency by antibody type
- Serious toxicity patterns
- Organ system impact
- Phase-specific analysis

## Troubleshooting

### Download Issues
- **Network timeout**: Try downloading during off-peak hours
- **File size**: The database is large (~1-2 GB), ensure sufficient space
- **Access denied**: Check if the AACT website is accessible

### Analysis Issues
- **Memory**: Large datasets may require significant RAM
- **Processing time**: Analysis may take 10-30 minutes
- **File permissions**: Ensure write access to output directory

## Alternative Approach
If you cannot download the full AACT database, you can:

1. **Use the sample analysis** with realistic simulated data
2. **Download specific antibody data** from ClinicalTrials.gov directly
3. **Use the existing sample data** for demonstration purposes

## Next Steps
1. Download the AACT database
2. Run the comprehensive analysis script
3. Review the generated reports and tables
4. Use the data for your research or clinical analysis

The comprehensive analysis will provide a complete picture of antibody therapeutic toxicities across all available clinical trial data.